EE614 Evaluating the Cost-Effectiveness of CYP2C19 Genetic Testing in Patients Who Have Experienced an Ischaemic Stroke or Transient Ischaemic Attack in England and Wales
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.879
https://www.valueinhealthjournal.com/article/S1098-3015(23)04009-3/fulltext
Title :
EE614 Evaluating the Cost-Effectiveness of CYP2C19 Genetic Testing in Patients Who Have Experienced an Ischaemic Stroke or Transient Ischaemic Attack in England and Wales
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04009-3&doi=10.1016/j.jval.2023.09.879
First page :
Section Title :
Open access? :
No
Section Order :
10373